Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation
about
Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung CancerPrognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy.The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapyOverall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic DiseasesAggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival.Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studiesX-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer.Adaptive hypofractionated gamma knife radiosurgery for a large brainstem metastasis.Prognostic factors analysis in EGFR mutation-positive non-small cell lung cancer with brain metastases treated with whole brain-radiotherapy and EGFR-tyrosine kinase inhibitors.Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasisPredicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of MetastasisPhase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases.Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancerAre immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literatureOligometastatic non-small-cell lung cancer: current treatment strategies.Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysisRisk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma.The evolving role of radiotherapy in treatment of oligometastatic NSCLC.Novel Treatment Strategies for Brain Metastases in Non-small-cell Lung Cancer.Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer.Prognostic significance of sites of extrathoracic metastasis in patients with non-small cell lung cancer.Distribution patterns of the metastases of the lung carcinoma in relation to histological type of the primary tumor: An autopsy study.Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?Tolerability and toxicity of prophylactic cranial irradiation in patients with non-small cell lung cancer - Results of a phase II study (with estimation of hematological toxicity, pituitary function and magnetic resonance spectra changes).Phase I study of bendamustine with concurrent whole brain radiation therapy in patients with brain metastases from solid tumors.Surgical approach in the oligometastatic patient.Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited.Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer.[Advances in diagnosis and treatment of brain metastases from the primary lung cancer].Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
P2860
Q33740707-5AE0CACE-FCC1-4780-9DD4-8EB772531036Q33847273-00BEBCE2-0230-45BE-94EE-AFB0380AAABAQ34781002-A7668DB8-820C-44E0-B170-5F4CD5A748D3Q35015692-FC4C8C64-BA49-40A6-AFFC-5E289D671785Q35882547-958CB0FB-5757-417A-BCC2-283F1BED585AQ36116869-F7614EC5-2376-4C68-B2EA-2C31707D9201Q36200218-0093AC58-3B0B-4824-9B30-BC82B11DFA9AQ36524116-E6093C82-9FAE-48D5-9495-33452BD4AEA4Q36612068-F0FD8B3C-86F0-497E-8A62-E424E118DF22Q36640303-5EC4AED3-BC8B-4FE2-97E6-9C73F6643753Q36772230-6F20BEBC-6CAC-43CD-8FF9-7D5A0B618C3EQ37011155-A164BB63-B1DF-4A39-B4B1-E16C66B33DE4Q37359663-D19ED642-F765-4D5E-9D78-008680A8AB88Q37368787-BE3CDED0-6BD0-443D-AE16-C433F4096F5DQ37584395-2FA1855D-A559-4AFA-BD40-B2A7759486C0Q37584420-E9212A0D-739C-4A5F-8CF5-2162E6EF9AC7Q37643566-E7CFA9A6-D211-4E06-B01D-73C0CB641720Q37677637-7FEAEAFF-D7AB-4CE6-A936-19A512C1AFD1Q37697247-C9BC9A83-D023-4509-AE68-F90EDDAA2A3BQ38625125-74C3D252-C036-4A18-A17E-06E3938ED349Q38809939-B8F26AB0-3E59-4704-9682-157B8C507A44Q38975455-8F0C984C-1203-4E55-A8C9-1AD5DFEC90F5Q38985337-18364995-E197-4809-B2A5-B8F20BED8CF3Q40070876-74036674-69AE-4C1F-9BDB-CC55E15E6FBDQ41231271-2EA6B41B-27E6-4D85-A00C-0AA8C9BE39BEQ42145859-C92F5206-2195-4E85-BD04-B43E077BEB41Q42949991-60361B57-AE3C-4F18-9D47-304EA1C8FBF2Q48695471-B277DC50-1E6D-4F09-8A3B-8D8D784202E7Q52581734-DE189F6E-8B57-48D6-9398-12846FF65DF3Q52715757-524D4797-508B-4066-8914-2FDE9AB04089Q55085494-C5A1CA63-59D6-4503-999C-C37B66E4895CQ55447607-510DFBE6-27AC-4572-A084-94441829ABE2Q58702829-6A4302CF-0CBE-44EA-B26A-EE8C90867141
P2860
Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Long-term survival in patients ...... py and thoracic chemoradiation
@ast
Long-term survival in patients ...... py and thoracic chemoradiation
@en
type
label
Long-term survival in patients ...... py and thoracic chemoradiation
@ast
Long-term survival in patients ...... py and thoracic chemoradiation
@en
prefLabel
Long-term survival in patients ...... py and thoracic chemoradiation
@ast
Long-term survival in patients ...... py and thoracic chemoradiation
@en
P2093
P2860
P356
P1433
P1476
Long-term survival in patients ...... py and thoracic chemoradiation
@en
P2093
Cynthia Villarreal-Garza
Diego G Zavala
Jaime de la Garza
Jesús Zamora
María D de la Mata
Mónika Blake-Cerda
Oscar Arrieta
Saé Muñiz-Hernández
P2860
P2888
P356
10.1186/1748-717X-6-166
P577
2011-11-25T00:00:00Z
P6179
1044130694